AzTrials
AzTrials

Ankle InjuriesNCT00718302

A Multicenter Randomized Trial Comparing Antiglide and Lateral Plate Fixation in Ankle Fractures

A study testing Antiglide Plate and Lateral Plate in people with Ankle Injuries, run by Boston Medical Center at 10 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The role of operative fixation of unstable, displaced lateral malleolus fractures is well-established (Mayer, Mak, and Yablon). However, the optimal type of fixation remains the subject of debate. Lag screw fixation alone is only appropriate for long oblique fractures in younger patients (Tornetta). Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Ankle Injuries
What is being tested?
Antiglide Plate and Lateral Plate
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
249 participants
Where
10 sitesin 2 countries
Study dates
Jun 2008to Dec 2012
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients aged 18 - 85
  • Closed Unstable Supination Eversion type Weber B fibula fracture
  • Soft tissue amenable to operative treatment
  • Opt for surgical treatment of their fracture
  • Willing to follow up for 1 year
  • Consent to be randomized

Who cannot join

  • Aged < 18 or over 85
  • Open fracture
  • Prisoners
  • Unlikely to followup
  • Non english speaking
  • Pre-existing arthrosis of the ankle
Show all 9Show fewer
  • Limitation in lower extremity function that would affect outcome scoring
  • Significant anterior comminution precluding antiglide fixation
  • Bilateral Fracture

Trial locations and contacts

10 sites in 2 countries.

10 sites in 2 countries

United States9 sites
  • Boston Medical Center

    Boston, Massachusetts, 02118

  • Ohio State University Medical Center

    Columbus, Ohio, 43210

  • Orthopaedic Specialty Associates Fort Worth

    Fort Worth, Texas, 76104

  • Orthopaedic Associates of Michigan

    Grand Rapids, Michigan, 49503

  • Indiana University

    Indianapolis, Indiana, 46202

  • Hennepin County Medical Center

    Minneapolis, Minnesota, 55415

  • New York Hospital for Joint Diseases

    New York, New York, 10003

  • University of Oklahoma/ Health Science

    Oklahoma City, Oklahoma, 73190

  • Barnes-Jewish Hospital

    St Louis, Missouri, 63110

Other trials in United States

Canada1 site
  • Dalhousie University

    Halifax, Nova Scotia

Other trials in Canada

About this study

Official title: Ankle Fracture Plating: A Multicenter Randomized Trial Comparing Lateral and Antiglide Plating in Displaced Lateral Malleolus Fractures

The role of operative fixation of unstable, displaced lateral malleolus fractures is well-established (Mayer, Mak, and Yablon). However, the optimal type of fixation remains the subject of debate. Lag screw fixation alone is only appropriate for long oblique fractures in younger patients (Tornetta). For all other patients, the choices for fibular stabilization most commonly involve the use of plates and screws which can be placed on either the lateral or posterior side of the bone, with or without lag screws. Lateral plating remains the most popular option, but since the description of posterior plating in 1982 (Brunner), reports in the literature have demonstrated some advantages of posterior over lateral plating (Ostrum, Treadwell, Winkler, and Wissing) . These advantages include less dissection, less palpable hardware, and decreased likelihood of intra-articular screw placement. However, there is only a single retrospective study in the published literature directly comparing these two methods (Lamontagne).

Read the detailed description

Since it was first described in 1982, posterior antiglide plating has been presented as an attractive alternative to lateral plating of distal fibula fractures. Biomechanical studies have shown it to be a stronger construct than lateral plating, and other purported advantages include less dissection, decreased potential for intra-articular screw placement, and less palpable hardware decreasing the need for hardware removal.However, although posterior plating has become an accepted technique for operative management of these injuries, there is little clinical information in the literature regarding this treatment, and only one published retrospective study directly comparing posterior to lateral plating.

In 1996, Ostrum published a prospective study evaluating posterior plating in 32 patients, but only compared his results to a cohort of patients treated with lateral plating that was not part of his actual study group.Patel et al. recently presented a retrospective comparison of both techniques, but their study only included 29 patients in the lateral plating group and 23 in the posterior group.In both these studies, posterior plating was felt to be superior to lateral plating based on both the decrease in complications/re-operations related to symptomatic hardware, and improved function and pain scores.

However, in a much larger study, Lamontagneet al. showed no differences in operative time, complications or hardware removal rates in 193 patients reviewed retrospectively, and concluded that they could not recommend one treatment method over the other. They even elected not to proceed with a planned prospective study based on their results.A recent retrospective analysis of 70 patients showed a 43% incidence of need for hardware removal due to pain, with 30% of these patients having peroneal tendon lesions identified intra-operatively.

Conditions
Ankle Injuries
Being tested
Antiglide Plate, Lateral Plate
Keywords
Ankle Fractures, Displaced Lateral Malleolus Fractures, Antiglide Plating, Lateral Plating
Medical subject headings
Ankle Injuries, Ankle Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Antiglide PlateDevice

    A plate is placed behind the broken ankle and secured with screws

  • Lateral PlateDevice

    A metal plate is placed to the side of the broken ankle and is secured with screws

Study groups in NCT00718302
Study groupRoleWhat they receive
Randomized treatment; antiglide plateExperimentalRandomized treatment; antiglide plate
Receives: Device: Antiglide Plate
Randomized treatment; lateral plateExperimentalRandomized treatment; lateral plate
Receives: Device: Lateral Plate

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of Nonpalpable Hardware

    Percentage of Participants with Nonpalpable Hardware

    Measured: 3 months, 6 months, 12 months

Secondary outcomes (4)
  1. Percentage Normal Peroneal Tendons

    Percentage of Participants with Normal Peroneal Tendons

    Measured: 3 months, 6 months, 12 months

  2. American Orthopedic Foot and Ankle Society Score (AOFAS) Scores

    American Orthopedic Foot and Ankle Society Score (AOFAS) score. The questionnaire consists of nine items that are distributed over three categories: Pain (40 points), function (50 points) and alignment (10 points). These are all scored together for a total of 100 points. A subject can score anywhere from 0-100, 100 being best.

    Measured: 3 months, 6 months, 12 months

  3. The Short Musculoskeletal Functional Assessment (SMFA) Score

    The Short Musculoskeletal Functional Assessment (SMFA) score. The questionnaire consists of four categories: Daily Activities, Emotional Status, Arm and Hand Function, Mobility. All categories are scored together, totaling between 0-100. The lower the score, the better the subjects function.

    Measured: 3 months, 6 months, 9 months

  4. SMFA - Bother Index

    The Bother Index is part of the SMFA. This section focuses on how much the injury is bothering the subject in terms of daily activities and use of injured area. The index totals are between 0-100. The lower the score, the less bothered the subject is by their injury.

    Measured: 3 months, 6 months, 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jul 2008 (estimated)
  2. Study startJun 2008
  3. Primary completionDec 2012
  4. Study completionDec 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
249 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00718302
Sponsor's protocol ID
H-27190
Status last verified
Feb 2017
First submitted
16 Jul 2008
Last updated
29 Mar 2017
Data monitoring committee
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Antiglide Plate and Lateral Plate in people with Ankle Injuries, run by Boston Medical Center at 10 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Mar 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 10 sites in United States, Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 29 Mar 2017). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of Nonpalpable Hardware (time frame: 3 months, 6 months, 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Mar 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in